Cargando…

Risk of Pneumococcal Disease in US Adults by Age and Risk Profile

BACKGROUND: Older age and certain medical conditions are known to modify the risk of pneumococcal disease among adults. We quantified the risk of pneumococcal disease among adults with and without medical conditions in the United States between 2016 and 2019. METHODS: This retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grant, Lindsay R, Meche, Aster, McGrath, Leah, Miles, Amanda, Alfred, Tamuno, Yan, Qi, Chilson, Erica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167987/ https://www.ncbi.nlm.nih.gov/pubmed/37180598 http://dx.doi.org/10.1093/ofid/ofad192

Ejemplares similares

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

906. Risk of Shingles among Patients Aged 45–49 versus 50–54 Years in the US, by Immune Status
por: Miles, Amanda C, et al.
Publicado: (2023)

Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2022)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
por: Vietri, Jeffrey, et al.
Publicado: (2019)

Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination
por: Grant, Lindsay R, et al.
Publicado: (2022)

1438. Uptake of 13-Valent Pneumococcal Conjugate Vaccine in High-Risk Adults Aged 19–64 Years: A Kaplan–Meier Approach
por: Vietri, Jeffrey, et al.
Publicado: (2018)

1404. Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
por: Lapidot, Rotem, et al.
Publicado: (2020)

Homelessness in Adults With Invasive Pneumococcal Disease in Calgary, Canada
por: Lemay, Julie-Anne, et al.
Publicado: (2019)

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults
por: Isturiz, Raul, et al.
Publicado: (2021)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Pneumococcal Carriage, Serotype Distribution, and Risk Factors in Children With Community-Acquired Pneumonia, 5 Years After Introduction of the 10-Valent Pneumococcal Conjugate Vaccine in Ethiopia
por: Negash, Abel Abera, et al.
Publicado: (2019)

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)
por: Hammitt, Laura L, et al.
Publicado: (2021)

Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
por: Lewnard, Joseph A, et al.
Publicado: (2022)

Population Attributable Fractions of Underlying Medical Conditions for Coronavirus Disease 2019 (COVID-19) Diagnosis and COVID-19 Hospitalizations, Ventilations, and Deaths Among Adults in the United States
por: Nguyen, Jennifer L, et al.
Publicado: (2022)

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?
por: Lesourd, Anaïs, et al.
Publicado: (2016)

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
por: Wasserman, Matt, et al.
Publicado: (2021)

Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US
por: McGrath, Leah J., et al.
Publicado: (2023)

Risk Factors for Septicemia Deaths and Disparities in a Longitudinal US Cohort
por: Kempker, Jordan A, et al.
Publicado: (2018)

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
por: Shea, Kimberly M., et al.
Publicado: (2014)

Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study
por: Naucler, Pontus, et al.
Publicado: (2021)

Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine
por: McGrath, Leah J., et al.
Publicado: (2023)

Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices
por: Pennant, Keyana N., et al.
Publicado: (2015)

White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia
por: Gardner, Julianna G., et al.
Publicado: (2017)

High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic
por: Hyle, Emily P, et al.
Publicado: (2022)

Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France
por: Danis, Kostas, et al.
Publicado: (2019)

Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia
por: Rombauts, Alexander, et al.
Publicado: (2020)

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021( )
por: Perniciaro, Stephanie, et al.
Publicado: (2022)

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years
por: Essink, Brandon, et al.
Publicado: (2021)

Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study
por: Danino, Dana, et al.
Publicado: (2021)

Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
por: Janoir, Claire, et al.
Publicado: (2016)

Human Immunodeficiency Virus (HIV) Treatment With Antiretroviral Therapy Mitigates the High Risk of Mental Health Disorders Associated With HIV Infection in the US Population
por: Ba, Djibril M, et al.
Publicado: (2023)

06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations
por: Vietri, Jeffrey, et al.
Publicado: (2021)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

A Leukocyte Score to Improve Clinical Outcome Predictions in Bacteremic Pneumococcal Pneumonia in Adults
por: Blot, Mathieu, et al.
Publicado: (2014)

Decreased Pneumococcal Carriage Among Older Adults in Denmark During the COVID-19 Lockdown
por: Tinggaard, Michaela, et al.
Publicado: (2023)

At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area
por: Woolley, Ann E, et al.
Publicado: (2022)

Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection
por: Sharninghausen, Jody C, et al.
Publicado: (2018)

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age
por: Trama, Jason P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r50b1450n37444238g0gtga269